Premature ejaculation (PE) is one of the most common forms of male sexual dysfunction, affecting approximately 13 to 30% of adult men. There are a limited number of treatment options currently available for men with PE.
If you or someone you know is affected by premature ejaculation, we invite you to participate in a clinical research study using an investigational drug for the treatment of PE. Insurance is not required.
Qualified participants will receive study-related care at no cost, and may be compensated up to $450 for time and travel. Call today to see if you qualify.